Therapy of Parkinson's Disease (eBook, PDF)

Redaktion: Pahwa, Rajesh; Koller, William; Lyons, Kelly E.

• Format: PDF

Produktbeschreibung

Offering a review of tactics in the therapeutic management of Parkinson's disease, this work presents summaries of salient research findings as well as contemporary attitudes and advice from field specialists. It also registers trends and progress in anti-parkinsonian medications, ablative surgical options and investigational therapies.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Taylor & Francis
• Seitenzahl: 592
• Erscheinungstermin: 19. April 2004
• Englisch
• ISBN-13: 9781135533700
• Artikelnr.: 55264222

Autorenporträt

Rajesh Pahwa, University of Kansas Medical Center, Kansas City. Kelly E. Lyons, Ph.D University of Kansas Medical Center. William Koller

Inhaltsangabe

Background: early iconography of Parkinson's disease
Christopher G. Goetz. Clinical aspects: epidemiology of Parkinsonism
Ali H. Rajput
Alex Rajput
and Michele Rajput; differential diagnosis of Parkinsonism
Kapil D. Sethi; pathophysiology and clinical assessment of Parkinsonian symptoms and signs
Joseph Jankovic; nonmotor symptoms of Parkinson's disease
Richard B. Dewey
Jr; neuropsychological aspects of Parkinson's disease and Parkinsonian syndromes
Alexander I. Troster and Steven Paul Woods; treatment of mental changes
Jorge Juncos; neuroimaging in Parkinson's disease
Kenneth Marek
Danna Jennings
and John Seibyl. Pathology and neurochemistry: neuropathology of Parkinsonism
Dennis W. Dickson; neurochemistry
Jayaraman Rao; neurophysiology/circuitry
Erwin Montgomery; animal models of Parkinson's disease and related disorders
Giselle M. Petzinger and Michael W. Jakowec; dopamine receptor diversity - anatomy
function
and relevance to Parkinson's Disease
Deborah C. Mash. Aetiology: genetics
Zbigniew K. Wszolek and Matthew Farrer; environmental risk factors for Parkinson's disease
Jay M. Gorell and Benjamin A. Rybicki. Medications: amantadine and anticholinergics
Joseph S. Chung
Allan D. Wu
and Mark D. Lew; levodopa
Anthony J. Santiago and Stewart A. Factor; dopamine agonists
Mark A. Stacy; monoamine oxidase inhibitors in Parkinson's disease
Daryl Victor and Cheryl Waters; catechol-o methyltransferase in Parkinson's disease
Ronald F. Pfeiffer; investigational pharmacological treatments for Parkinson's disease
William Ondo. Surgical therapy: lesion surgeries
Michael Samuel and Anthony E. Lang; deep brain stimulation in Parkinson's disease
Rajesh Pahwa and Kelly E. Lyons; neural transplantation in Parkinson's disease
Elmyra V. Encarcion and Robert A. Hauser. Other forms of treatment: Parkinson's disease symptom management - an interdisciplinary approach
Ruth A. Hagestuen
Rosemary L. Wichmann
and Marjorie L. Johnson.